Back to Journals » Lung Cancer: Targets and Therapy » Volume 10

Differential response to a combination of full-dose osimertinib and crizotinib in a patient with EGFR-mutant non-small cell lung cancer and emergent MET amplification

Total article views   Abstract views HTML views PDF downloads Totals
3,949 Dovepress* 2,587 416+ 1,060 3,003
PubMed Central* 0 946 262 946
Totals 2,587 1,362 1,322 3,949
*Since 12 March 2019
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 1 0 0 1 2

View citations on PubMed Central and Google Scholar